Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)

NCT02167035 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Combigan Two Times Daily (BID)
DRUG: Simbrinza Three Times Daily (TID)

Sponsor

Cornerstone Health Care, PA

Collaborators

[object Object]